
Menopause is everywhere. But is everyone being heard?
Menopause awareness is growing, but inequities in access, symptom burden and clinician confidence may leave some women unheard.
Medicine Central expert articles
Evidence-led articles for UK primary care from Medicine Central contributors, bringing practical clinical perspective and research insight together.
Want to write for us?
We welcome relevant, evidence-led perspectives for UK primary care. Tell the editorial team about your proposed contribution and expertise.
These articles bring named contributors' perspectives to clinical evidence, professional learning and the day-to-day questions faced in UK primary care. Browse the newest articles below, or explore our clinical evidence library and free CPD webinars for related learning.
Expert articles
All published contributor articles, newest first.

Menopause awareness is growing, but inequities in access, symptom burden and clinician confidence may leave some women unheard.

Dr Saira Bano explains why BMI is a starting point—not the whole assessment—and how waist-to-height ratio, HbA1c, blood pressure, lipids and cardiovascular risk help build a clearer metabolic picture in primary care.

Iatrogenic menopause is associated with a higher risk of cardiovascular disease, while menopause before 45 is associated with higher cardiovascular and all-cause mortality.


Dr Fatima Tahir explains the safeguards that underpin clinical trials in general practice, from ethical review and informed consent to Good Clinical Practice and ongoing safety monitoring.


This is a chance for women to get their mojo back.


NICE TA1152 establishes semaglutide 2.4 mg as a secondary cardiovascular-prevention treatment for adults with established cardiovascular disease and a BMI of at least 27 kg/m². Niraj Lakhani considers what this means for primary care.


CKD is common, but progression is not inevitable.

Almost 90% of NHS patient contacts happen in primary care, yet most research still happens somewhere else. Dr Fatima Tahir on why that gap matters, and what practices stand to gain from closing it.

Despite excellent LDL-cholesterol management, 1 in 3 patients with established ASCVD will experience a recurrent event within three years. Elevated triglycerides represent a major — yet frequently overlooked — driver of residual cardiovascular risk. Moudy Khodadi, Advanced Pharmacist Lipid Clinic, explains the mechanism, the evidence, and what actually works.

This week, our expert insights will guide you through a case study from Jan Brassington’s webinar, ‘Managing Pain in Palliative Care.’ You can now watch it as an on-demand video on our CPD Webinars page!

Patients are arriving in clinic with curated supplement stacks, convinced that longevity science has delivered a shortcut to a longer, healthier life. The evidence tells a more sobering story.

PCOS has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) following international consensus in 2026. This expert update covers the new diagnostic criteria, holistic management approach, and what this means for primary care.

Three NICE pathways for the same class of drug, each with its own eligibility criteria, funding route, and stopping rule. Kashif Shakoor maps a practical route through the complexity.

Around one in five adults have abnormal liver blood results. However, in the BALLETS primary care group, only 2.5% had a specific liver disease.


Blood pressure management sits at the heart of cardiovascular prevention, yet many patients remain under-treated against optimal targets.

Primary care routinely measures blood pressure, BMI and smoking status; however, one of the strongest predictors of long-term health outcomes is often left unassessed - sleep.

What UK primary care needs to understand about the grey market peptide trade
Rising ADHD referrals means more GPs managing shared-care stimulant prescribing. This week's article is a GP guide to shared-care monitoring, red flags and drug interactions, with a free downloadable cheat sheet.
Dr Frederick Reynolds, a GP using ambient scribes day-to-day, has written the kind of thoughtful, first-hand review these tools deserve.
From raised LDL to a new non-hormonal drug class and the largest HRT safety study to date, this week is all menopause in primary care.